InnoCare
Overview
InnoCare is a Chinese biopharmaceutical company specializing in developing innovative therapies for cancer and autoimmune diseases. The company focuses on discovering, developing, and commercializing first-in-class and best-in-class drugs to address unmet medical needs in these areas. InnoCare has established a comprehensive platform that spans from innovation and clinical development to production and commercialization, aiming to deliver high-quality treatments to patients worldwide. InnoCare's investment strategy involves providing funding to technology-based companies, particularly in the biotechnology and pharmaceutical sectors. The firm has a history of investing in early-stage to growth-stage companies, supporting their development and expansion. InnoCare's portfolio includes companies involved in drug discovery, clinical trials, and medical research, reflecting its commitment to advancing healthcare through innovation. The firm's investment philosophy centers on fostering innovation and supporting the growth of companies that contribute to advancements in medical treatments. InnoCare's track record includes investments in companies like Briya, a technology-based firm, demonstrating its focus on supporting ventures that align with its mission to improve patient outcomes through innovative solutions.
Investment Focus
- Technology-based companies
- Biotechnology and pharmaceutical sectors
- Early-stage to growth-stage companies
- Alignment with InnoCare's mission to improve patient outcomes through innovation
Portfolio Companies
Reach InnoCare directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about InnoCare
What sectors does InnoCare invest in?
InnoCare invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Medical Research, and is based in L'état Et Le Pays 92250, France. InnoCare is listed as a venture capital in the ConnectSafely investor database.
What stage does InnoCare invest at?
InnoCare backs companies at Early Stage, Series A, Series B, Growth, Late Stage and Pre-IPO.
Which regions does InnoCare invest in?
InnoCare invests across United States, Hong Kong, Singapore and China.
What companies has InnoCare invested in?
InnoCare's portfolio includes Briya.
How do I contact InnoCare?
InnoCare's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
